Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (153506)	2/23/2020 4:36:36 PM
From: 3bar	Read Replies (1) \| Respond to of 218847

Compound passes threw blood brain barrier . X rays seems to be what they are talking about . Phase 1 on any new drug trial for FDA is to see if humans can tolerate . Not only passed with colors flying but unheard of killing of all bladder cancer weather small test dose or regular treatment size . That was on bladders whose owners chose this treatment rather than have bladder removed . Worst of the worst going home happy . Details get things complicated aka so there is more to it .